PPL
54
-5
CA
38
6
EL
25
4
XRX
44
3
PFG
45
3
HCP
66
8
VRSN
53
-4
INTU
56
-4
FSLR
54
7
VZ
50
3
SYY
53
4
KHC
24
13
M
37
12
INTC
33
-2
APD
59
2
ES
34
3
CINF
53
2
IBM
58
-2
EMN
60
4
PFE
23
7
PPL
54
-5
CA
38
6
EL
25
4
XRX
44
3
PFG
45
3
HCP
66
8
VRSN
53
-4
INTU
56
-4
FSLR
54
7
VZ
50
3
SYY
53
4
KHC
24
13
M
37
12
INTC
33
-2
APD
59
2
ES
34
3
CINF
53
2
IBM
58
-2
EMN
60
4
PFE
23
7
Financhill
Back

The Cooper Companies 10K Form

Buy
56

COO
The Cooper Companies

Last Price:
103.13
Seasonality Move:
6.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive COO News And Ratings

See the #1 stock for the next 7 days that we like better than COO

COO Financial Statistics

Sales & Book Value

Annual Sales: $3.59B
Cash Flow: $118.5M
Price / Cash Flow: 106.58
Annual Sales: $39.80
Price / Book: 2.53

Profitability

EPS (TTM): 1.79500
Net Income (TTM): $359.3M
Gross Margin: $2.36B
Return on Equity: 4.67%
Return on Assets: 3.02%

The Cooper Companies Earnings Forecast

Key The Cooper Companies Financial Ratios

  • The Gross Profit Margin over the past 40 years for COO is 65.62%.
  • The Selling, General & Administrative Expenses for COO have been equal to 41.78% of Gross Profit Margin.
  • The Research & Development expenses have been 3.82% of Revenue.
  • The Interest Expense is 35.79% of Operating Income.
  • The Net Earning history of COO is 8.19% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 25 years.

The Cooper Companies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: COO
CUSIP: 216648
Website: coopercos.com

Debt

Debt-to-Equity Ratio: 0.33
Current Ratio: 1.99
Quick Ratio: 0.88

Price-to-Earnings

Trailing P/E Ratio: 68.22
Forward P/E Ratio: 22.26

COO Technical Analysis vs Fundamental Analysis

Buy
56
The Cooper Companies (COO) is a Buy

Is The Cooper Companies a Buy or a Sell?